In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections.

ribavirin - Generic mfg.

Synagis (palivizumab) - AbbVie, AstraZeneca, SOBI

Asceniv (intravenous immunoglobulin) - ADMA Biologics

http://www.ncbi.nlm.nih.gov/pubmed/37542818

Ann R Falsey; Bindiya Bagga; Brian E Gilbert; Guy Boivin; James Mond; Jesse Papenburg; John P DeVincenzo; Kacy A Ramirez

Aug 6, 2023